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Abstract
Genotoxicity assessment is of great significance in drug safety evaluation, and microarray is a useful tool widely used to
identify genotoxic stress responsive genes. In the present work, by using oligonucleotide microarray in an in vivo model, we
identified an unknown gene BC005512 (abbreviated as BC, official full name: cDNA sequence BC005512), whose expression
in mouse liver was specifically induced by seven well-known genotoxins (GTXs), but not by non-genotoxins (NGTXs).
Bioinformatics revealed that BC was a member of the GLN family of murine endogenous retrovirus (ERV). However, the
relationship to genotoxicity and the cellular function of GLN are largely unknown. Using NIH/3T3 cells as an in vitro model
system and quantitative real-time PCR, BC expression was specifically induced by another seven GTXs, covering diverse
genotoxicity mechanisms. Additionally, dose-response and linear regression analysis showed that expression level of BC in
NIH/3T3 cells strongly correlated with DNA damage, measured using the alkaline comet assay,. While in p53 deficient
L5178Y cells, GTXs could not induce BC expression. Further functional studies using RNA interference revealed that down-
regulation of BC expression induced G1/S phase arrest, inhibited cell proliferation and thus suppressed cell growth in NIH/
3T3 cells. Together, our results provide the first evidence that BC005512, a member from GLN family of murine ERV, was
responsive to DNA damage and involved in cell growth regulation. These findings could be of great value in genotoxicity
predictions and contribute to a deeper understanding of GLN biological functions.
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Introduction
Genotoxicity assessment plays an important role in both toxicity
screening during early drug discovery and regulatory drug safety
evaluation in the preclinical stage [1]. Although a great number of
genotoxicity assays have been developed, there is still a requirement
for tests with both high specificity and sensitivity [2]. The use of
microarray technology in toxicology, known as toxicogenomics, can
potentially identify novel genotoxicity biomarkers and provide
mechanistic insights into the mode of action of genotoxic compounds
[3,4,5,6,7,8]. We identified an unknown gene BC005512 (official full
name: cDNAsequence BC005512),whoseexpression was specifically
induced by genotoxins (GTXs) but not by non-genotoxins (NGTXs)
in an in vivo microarray study. Elevated expression of BC005512 has
been reported previously in thymocytes of Parp-2 deficient mice [9],
suggesting that it is relevant to DNA damage. Further analysis of this
gene uncovered that it is a member of the GLN family of murine
endogenous retrovirus (ERV).
ERV sequences, most probably originating from infections of
germ-line cells by ancient exogenous retroviruses during evolution
[10], account for approximately 8% of the human genome [11] and
10% of the mouse genome [12]. ERVs were once thought to be junk
DNA, but a number of studies have shown that some have important
physiological roles [13,14,15] or are implicated in certain diseases
[16,17]. Several studies have reported elevated expression of ERV-
related sequences in hepatocarcinogen treated rodents [18,19].
The GLNfamily, designated due to an unusualprimer-binding site
sequence corresponding to tRNA
Gln, is one of a number of murine
ERV families. It was first identified over two decades ago [20], but
remains little-studied [21,22]. The relationship between GLN and
genotoxic stress and the biological function of GLN family members
are largely unknown. Here we report that BC005512, a member of
theGLNfamilyofmurineERV,wasresponsivetoDNAdamageand
involved in regulation of cell growth.
Results
1. Selection of specific and sensitive genotoxic stress
responsive genes using microarray
Microarray is a powerful way of examining genomic scale gene
expression changes. To identify specific and sensitive genotoxic
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specifically investigating liver tissue in B6C3F1 mice administered
with seven well-characterized genotoxins (GTXs) and three non-
genotoxins (NGTXs). Compounds with all negative data in
regulatory genotoxicity assays (including Ames test, in vitro
chromosome aberration test, mouse lymphoma assay and in vivo
micronucleus test) were chosen as non-genotoxins. The dosage
used for GTXs was selected based on data from in vivo transgenic
mouse mutation assays, where significantly higher mutant
frequencies were observed in liver tissue. The mutant frequency
was determined as described previously [23]. While the dosage
used for NGTXs was 1/2 LD50 (Table 1). To study both early and
late or sustained genotoxic stress responses, time points at 4 h,
20 h, 2 weeks and 4 weeks after treatment were chosen. To select
genotoxic stress responsive genes, we adopted a self-defined weight
scoring approach. Candidate genes were scored based on their
specificity, sensitivity (including average ratio, positive condition,
positive chemical and reverse change), statistical P value, basal
expression level, and coefficient of variation (CV). A total score,
considering all the above parameters, was finally calculated
(Table 2). Further analysis of the top ranked 50 genes by
hierarchical clustering showed clear gene sets, whose expression
could distinguish GTXs from NGTXs (Fig. 1A). These included
some well-known DNA damage inducible genes e.g. p21
WAF1/Cip1
[24] and ccng1 [25]. The highest scoring gene was an unknown
gene BC005512 (identified by probe set 1426936_at, Gene
symbol: BC005512, official full name: cDNA sequence
BC005512). Its expression was specifically induced by GTXs,
but not by NGTXs, which was further confirmed by quantitative
real-time PCR (Fig. 1B and 1C).
2. BC005512 is a member of the GLN family of murine
endogenous retrovirus
To characterize BC005512 in the mouse database, we
performed bioinformatics analysis. A nucleotide BLAST search
using the genechip probe sequence (Fig. S1) as the query identified
two cDNAs (GenBank accession no. BC005512 and BC062922).
Analysis of both sequences using ORF finder (http://www.ncbi.
nlm.nih.gov/gorf/gorf.html) and protein BLAST revealed that the
putative proteins encoded by these sequences have great similarity
to retrovirus related proteins encoded by env genes of mouse ERV
(data not shown) [10]. To determine the relationship of BC005512
with mouse ERVs, we analyzed BC005512 and BC062922
sequences using an online CENSOR program (http://www.
girinst.org/censor/index.php), which screens query sequences for
interspersed repeats [26]. The sequence analysis classified them
into ERV-Class I, and revealed strong similarities to
MMERGLN_I, a sequence submitted as one copy of GLN family
in Repbase (Fig. 2). These findings suggested that the sequence
identified in the above microarray study, i.e. BC005512
(abbreviated as BC in the following text), was a member of the
GLN family of murine ERV.
3. Expression of BC was specifically induced by
genotoxins in NIH/3T3 cells
The microarray study showed that BC was induced by
genotoxic stress in vivo. To further characterize the responsiveness
of BC to GTXs in vitro, we tested another seven GTXs with
different genotoxic mechanisms and two NGTXs (Table 3). For
each GTX, 24 h IC50 was determined and used to study the effects
of treatment on BC expression. NIH/3T3, a well-characterized
mouse embryonic fibroblast cell line, was used as the in vitro model
system. In accordance with results obtained in vivo, all seven GTXs
up-regulated expression of BC to varying degrees, while all three
NGTXs tested had no obvious effects on BC expression in NIH/
3T3 cells (Fig. 3). Similar results were also obtained in a mouse
hepatoma cell line, Hepa 1–6 cells (Fig. S2).
4. Induced expression level of BC correlated with DNA
damage in NIH/3T3 cells
Inducing DNA damage is one of many genotoxicity mecha-
nisms. To further study the relationship between BC expression
and DNA damage, we compared transcriptional expression level
of BC and the extent of DNA damage using methyl methanesul-
fonate (MMS) as a DNA-reactive model compound [27]. MMS
was chosen as it gave the strongest response in the in vitro BC
induction assay (Fig. 3) and has been used extensively as a DNA
damaging model agent. MMS modifies both guanine (to 7-
methylguanine) and adenine (to 3-methlyladenine) causing base
mispairing and replication blocks, respectively [27]. DNA damage
was indicated by olive tail moment in the alkaline comet assay
[28]. As shown in Fig. 4A and 4B, MMS induced a concentration-
dependent increase in both BC expression and DNA damage.
In addition to DNA-reactive chemicals, aneugens that directly
target spindles but not DNA during chromosome segregation were
another class of GTXs. To determine whether BC was responsive
to aneuploidy, we examined the effects of two aneugens, colchicine
[29] and paclitaxel [30], on BC expression. Chromosome
abnormality was determined using the micronucleus test [31].
The highest concentration of paclitaxel or colchicine was limited
to 48 h IC50. As expected, both colchicine and paclitaxel induced
a dose-dependent increase in micronucleus formation (Fig. 4F and
4I) but not in DNA damage except at very high concentrations,
possibly due to nonspecific effects under cytotoxic conditions (bar
graph in Fig. 4D and 4G, 4E and 4H). In accordance with MMS
treatment, quantitative PCR analysis showed that expression level
of BC was in parallel with DNA damage i.e., BC induction only
occurred when DNA damage was observed, regardless of whether
aneuploidy was induced (line graph in Fig. 4D and 4G).
Furthermore, the linear regression analysis of data obtained from
MMS, colchicine and paclitaxel revealed a strong correlation
between expression level of BC and the extent of DNA damage
(Fig. 4C).
5. Expression of BC could not be induced by GTXs and
did not correlate with DNA damage in L5178Y cells
In addition to NIH/3T3 cells, L5178Y, a widely used mouse
lymphoma cell line in in vitro genotoxicity assays was also adopted
to investigate the effects of GTXs on BC expression and the
relationship between BC expression and DNA damage. For each
GTX, 24 h IC50 was determined and used in L5178Y cells.
Surprisingly, GTXs that substantially induce BC expression in
NIH/3T3 cells did not show similar effects in L5178Y cells (Fig. 5A
and Fig. S3). Concordantly, expression level of BC did not
correlate with DNA damage induced by MMS (Fig. 5B, 5C and
5D). Together, these results suggested that expression of BC could
not be induced by GTXs and did not correlate with DNA damage
in L5178Y cells.
6. Down-regulating BC expression suppressed cell
growth in several mouse cell lines
DNA damage triggers a variety of biological responses including
the transcriptional activation of genes regulating DNA repair, cell
cycle checkpoint and cell death [32]. The observation that BC was
responsive to DNA damage raised the question whether BC was
involved in these processes.
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Compounds Abbr
1 CAS
2 No. Dosage (mg/kg) Classification
Dimethylnitrosamine DMN [23] 62-75-9 5 Genotoxins
Diethylnitrosamine DEN [46] 55-18-5 80
Ethyl nitrosourea ENU [47] 759-73-9 150
Dipropylnitrosamine DPN [48] 621-64-7 250
o-Aminoazotoluene AAT [49] 97-56-3 300
Dibenzo[a,l]pyrene DBP [50] 191-30-0 6
7,12-Dimethylbenz[a]anthracene DMBA [48] 57-97-6 20
Ethanol EtOH 64-17-5 1000 Non-genotoxins
Phenobalbital sodium PB 57-30-7 30
Diethylhexylphthalate DEHP 117-81-7 2000
1Abbr: Abbreviation;
2CAS: Chemical Abstracts Service.
doi:10.1371/journal.pone.0035010.t001
Table 2. Weight score for genotoxic stress responsive gene selection in the in vivo microarray study (liver, B6C3F1).
Systematic Specificity Ave ratio
Positive
condition
Positive
chemical P value Basal
Reverse
change CV (%)
TOTAL
SCORE Common
V
1 S
2 V S V S VS VS VS VS VS
1426936_at 1.00 5 10.62 5 11.5 5 6 5 0.14 5 0.92 0 0.0 2 64 2 32.0 BC005512
1417185_at 1.00 5 3.98 2 14.5 5 6 5 0.07 5 2.35 3 0.0 2 27 4 31.5 Ly6a
1433691_at 1.00 5 3.31 2 5.0 2 5 4 0.21 4 2.64 4 2.0 5 24 4 28.5 Ppp1r3c
1449002_at 1.00 5 4.40 2 12.0 5 6 5 0.33 2 1.80 1 0.0 2 26 4 27.5 Phlda3
1421040_a_at 1.00 5 2.49 2 5.5 2 5 4 0.18 4 2.63 4 0.0 2 33 4 27.0 Gsta2
1424638_at 0.83 3 24.58 5 15.0 5 7 5 0.19 4 1.51 0 0.0 2 70 2 27.0 Cdkn1a
1450016_at 1.00 5 3.26 2 11.0 5 5 4 0.35 1 2.13 2 0.0 2 12 5 26.5 Ccng
1450017_at 1.00 5 4.55 2 11.0 5 5 4 0.29 2 1.79 1 0.0 2 23 4 26.5 Ccng
1420827_a_at 0.92 4 7.88 4 11.0 5 5 4 0.33 2 1.75 1 0.0 2 43 3 26.0 Ccng
1416578_at 1.00 5 2.88 2 5.0 2 5 4 0.17 4 1.92 1 0.0 2 35 4 25.5 Rbx1
1424744_at 1.00 5 2.42 0 6.5 3 6 5 0.46 0 3.01 5 2.0 5 33 4 25.0 Sds
1425631_at 1.00 5 3.72 2 4.0 1 4 2 0.15 5 2.09 2 4.0 5 38 3 25.0 Ppp1r3c
1416125_at 1.00 5 2.49 2 5.0 2 4 2 0.12 5 2.28 3 0.0 2 71 2 24.5 Fkbp5
1419874_x_at 0.90 4 5.77 3 9.0 4 5 4 0.15 5 1.37 0 21.0 1 107 0 24.5 AI467657
1427422_at 0.83 3 3.15 2 10.0 5 6 5 0.27 3 1.99 1 1.0 3 46 3 24.5 BM122014
1442026_at 0.83 3 3.70 2 10.0 5 5 4 0.11 5 1.62 0 0.0 2 50 3 24.5 AI467657
1416926_at 0.86 3 3.37 2 12.0 5 6 5 0.31 2 2.25 2 0.0 2 24 4 24.0 Stinp
1448265_x_at 1.00 5 2.55 2 7.5 3 6 5 0.36 1 2.02 2 21.0 1 52 3 24.0 Eva
1455892_x_at 0.91 4 2.52 2 10.5 5 5 4 0.48 0 2.92 5 1.0 3 80 2 24.0 BB794742
1418787_at 1.00 5 1.89 0 5.0 2 5 4 0.31 2 3.16 5 0.0 2 13 4 23.5 Mbl2
1‘‘V’’ represents values.
2‘‘S’’ represents score. Only the top 20 genes are shown. A full list is attached in Table S3.
Detailed scoring rules are described in the supporting information. ‘‘Pink cells’’ represent up-regulation and ‘‘blue cells’’ represent down-regulation.
Specificity=(number of total pink cells in GTXs)/(number of total pink cells in GTXs and NGTXs); Ave ratio=average of ratios of all pink cells in GTXs; Positive
condition=number of total pink cells in GTXs. Since DEN was duplicated, each pink cell was considered 0.5; Positive chemical=number of GTXs with at least one
pink cell; P value was calculated by t test of signal intensity between GTXs and NGTXs in GeneSpring software; Basal represents basal expression level, equals to log10
value of signal intensity of control animals; Reverse change reflects opposite change of gene expression in different treatment groups. Reverse change=number of
blue cells in NGTXs - number of blue cells in GTXs; CV%=100 6SD/MEAN% based on the signal intensity of all control animals. Total score=Score of 26Specificity +
Ave ratio + Positive condition + Positive chemical + P value + 0.56Basal + 0.56Reverse change + 0.56CV%.
doi:10.1371/journal.pone.0035010.t002
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on cell growth by RNA interference. Two BC siRNAs were
designed; one nonsense siRNA and two corresponding scrambled
siRNAs were used as negative controls. Quantitative PCR showed
that at 48 h after siRNA transfection, the level of BC mRNA was
markedly reduced in cells transfected with BC siRNAs (siBC.1 and
siBC.2) compared with cells transfected with nonsense (Fig. 6A) or
scrambled siRNAs (Fig. S4A). Due to the lack of appropriate
antibody against BC, to confirm the knock-down efficiency of BC
siRNAs at the protein level, we generated a myc-tagged BC clone.
Following co-transfection of the clone and BC siRNA into NIH/
3T3 cells, the protein expression level of BC was monitored using
Figure 2. BC005512 is a member of the GLN family of murine endogenous retrovirus. Sequence alignment between BC005512, BC062922
and MMERGLN_I. Locations of the genechip probe, quantitative PCR primers (BC-F and BC-R) and BC siRNAs are shown.
doi:10.1371/journal.pone.0035010.g002
Figure 1. Selection of sensitive and specific genotoxic stress responsive genes. (A) Hierarchical clustering of top 50 scored up-regulated
genes shown in gene symbol. Red and green indicate up-regulation and down-regulation, respectively. The orange box represents genes whose
expression could distinguish GTXs from NGTXs. The blue box represents the gene with the highest score, BC005512. (B and C) Microarray and
quantitative PCR (qPCR) data showing BC expression levels in livers of mice dosed with indicated chemicals at 4 h or 20 h after administration.
Microarray data represented pooled samples from 4 animals per group. Quantitative PCR data were mean 6 s.d. (n=4).
doi:10.1371/journal.pone.0035010.g001
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mutations into the siBC.2 target region to generate a mutant
clone. By co-transfecting this mutant clone and siBC.2 into NIH/
3T3 cells, we further examined the specificity of siBC.2. As shown
in Fig. S5, siBC.2 decreased the wild-type BC, but not the mutant
BC protein levels, indicating that siBC.2 worked specifically and
effectively at the protein level.
Cell growth analysis of NIH/3T3 cells transfected with BC
siRNAs showed that the total cell number was markedly reduced
compared with cells transfected with nonsense (Fig. 6B) or
scrambled siRNAs (Fig. S4B). Similar results were also obtained
in a mouse hepatoma cell line Hepa 1–6 (Fig. 6C and 6D), and a
mouse glomerular mesangial cell line SV40 MES 13 (Fig. 6E and
6F). These results suggested that knock-down of BC expression
suppressed cell growth in several mouse cell lines.
7. Knock-down of BC induced G1/S phase arrest and
inhibited cell proliferation in NIH/3T3 cells
To investigate whether BC affected cell growth due to its effect
on cell proliferation or cell survival, we performed an EdU
incorporation assay, which is similar to BrdU incorporation assay.
As shown in Fig. 7A and 7B, fewer EdU-positive cells were found
in BC siRNAs-transfected cells (30.3%61.2% for siBC.1, and
19.0%61.9% for siBC.2) than in nonsense siRNA-transfected cells
(39.5%62.0%), indicating that knock-down of BC suppressed
NIH/3T3 cells proliferation.
To elucidate how knock-down of BC can suppress cell
proliferation, we examined the effects of knocking-down BC on
cell cycle. At 48 h after transfection, the percentage of cells in G0/
G1 phase was substantially increased (60.560.3 for nonsense
siRNA, 69.761.0 for siBC.1 and 78.761.3 for siBC.2) with a
concomitant reduction of cells in S phase (25.960.5 for nonsense
siRNA, 20.860.7 for siBC.1 and 11.761.4 for siBC.2, Fig. 7C, 7D
and Fig. S4C).
To determine whether down-regulation of BC expression
affected cell death, we examined apoptosis in NIH/3T3 cells by
flow cytometry using Annexin V and propidium iodide double
staining. Knock-down of BC did not induce apoptosis at 48 h after
siRNA transfection (Fig. S6A). Consistently, no obvious sub-G1
peak was observed (Fig. 7C), indicating that down-regulation of
BC did not induce apoptosis directly in NIH/3T3 cells.
Nevertheless, the obvious apoptosis observed at 96 h after siRNA
transfection (Fig. S6B) might be caused by cell cycle arrest,
occurring at 48 h after transfection.
Taken together, these results suggested that down-regulation of
BC induced G1/S arrest, and thus inhibited cell proliferation in
NIH/3T3 cells.
Discussion
In this work, we have shown that BC005512, a member of the
GLN family of murine ERV, was responsive to DNA damage.
This conclusion was supported by several observations. Multiple
well-characterized GTXs with a diversity of genotoxicity mech-
anisms induced elevated expression of BC both in vivo (mouse liver)
and in vitro (NIH/3T3 cells). More specifically, a strong correlation
Figure 3. Expression of BC was specifically induced by GTXs in NIH/3T3 cells. Data from quantitative PCR showing transcriptional
expression of BC in NIH/3T3 cells treated with genotoxic or non-genotoxic chemicals for indicated time. Data were mean 6 s.d. of three independent
experiments.
doi:10.1371/journal.pone.0035010.g003
Table 3. Model compounds selected in the in vitro BC induction study.
Compounds Abbr. CAS No. Primary modes of action Concentration Classification
NIH/3T3 L5178Y
Camptothecin CPT 7689-03-4 Topoisomerase I poison [51] 25 mM 2.87 mM Genotoxins
tert-Butyl hydroperoxide TBHP 75-91-2 Reactive oxygen species [52] 50 mM— —
c-ray IR —— Ionizing radiation 8 Gy 10 Gy
Mitomycin C MMC 50-07-7 Bi-functional cross-link alkylating agent [53] 30 mM6 mM
Etoposide ETOP 33419-42-0 Topoisomerase II poison [54] 50 mM1 . 7 mM
Cisplatin CDDP 15663-27-1 Crosslink agent [55] 12.5 mM— —
Methyl methanesulfonate MMS 66-27-3 Mono-functional alkylating agent [27] 0.5 mM ——
Acetonitrile ACN 75-05-8 10 mM 10 mM Non-genotoxins
Ethanol EtOH 64-17-5 10 mM 10 mM
Sucrose SUC 57-50-1 10 mM 10 mM
doi:10.1371/journal.pone.0035010.t003
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35010Figure 4. Induced expression level of BC correlated with DNA damage in NIH/3T3 cells. (A, B, D, E, G and H) Comparison between
expression level of BC and DNA damage in NIH/3T3 cells exposed to MMS (A, B) for 8 h, or to colchicine (D, E) or paclitaxel (G, H) for 24 h. DNA
damage was measured by olive tail moment (tail length6percentage of DNA in tail) in an alkaline comet assay (representative figures are shown in
B, E and H). Data were mean6s.d. of three independent experiments. (C) Linear regression analysis between expression level of BC and DNA damage,
reflected by olive tail moment. Each dot represents the mean of data shown in (A), (D) and (G). (F and I) Micronucleus frequency in NIH/3T3 cells
exposed to colchicine or paclitaxel for 24 h. Data were mean 6 s.d. of three independent experiments. Values shown on top of bars are P values vs
control.
doi:10.1371/journal.pone.0035010.g004
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damage. Besides the above findings, we provide the first evidence
that BC was involved in cell growth regulation, suggesting that BC
was biologically relevant to the DNA damage response.
Recent studies have reported elevated expression of ERVs in
many different types of human cancers or tumor cell lines [17].
UVBirradiation was reported toinducetranscriptionalactivationof
ERV sequences in human epidermal keratinocytes [33]. However,
the relationship between GLN and DNA damage was not clear.
This is the first report that demonstrates the involvement of a GLN
family member in genotoxic stress, particularly in the DNA damage
response. This quantitative DNA damage-responsive property of
BC could be potentially useful in genotoxicity prediction.
In addition to BC, we identified another ERV with a high score
(1455892_x_at, BB794742, mouse endogenous murine leukemia
virus mRNA), whose expression was induced by GTXs (Table 2). A
great number of human ERVs have been reported to have perfect
p53 binding sites that not only regulate adjacent gene expression,
but may also give ERVs the advantage of exiting the host cell for
their own survival under stress conditions [14]. As discussed later,
we also found that the long terminal repeat (LTR) of GLN has a
putative p53 binding site. Combined with our findings, it would be
of great interest to study the relationship between ERVs and stress
responses, and determine whether ERVs have intrinsic advantages
in becoming potential genotoxicity biomarkers.
In the microarray study, BC was initially identified using self-
defined weight scoring. In our scoring system, well-known DNA
damage responsive genes such as p21 [24] and ccng1 [25] were also
assigned high scores, indicating that this method worked effectively
in identifying genotoxic stress inducible genes. Although the basal
expression level was low, BC had priority over other candidate
genes in its high specificity and sensitivity (Table 2). However, it
should be notedthat this would not exclude the possibility that other
genes could become potential genotoxicity biomarkers.
Transcriptional expression of BC was induced by GTXs in
NIH/3T3 cells, but not in L5178Y cells. We inferred that this
discrepancy might be due to a lack of functional p53 in L5178Y
cells [34]. A search for transcriptional factor binding sites revealed
that GLN LTR has a putative p53 binding site (Fig. S7A). In a
preliminary study on the mechanisms of BC expression regulation
in NIH/3T3 cells, we found that the wild-type LTR had great
promoter/enhancer activity, even stronger than the positive
control using luciferase reporter gene assay (Fig. S7B). However,
when the putative p53 binding site was deleted, the promoter/
enhancer activity dropped significantly (Fig. S7B). To address the
role of p53 in BC induction, we examined the effects of treatment
with pifithrin-alpha (PFT-a), a widely used p53 inhibitor [35], on
BC expression in NIH/3T3 cells. Consistent with our expecta-
tions, treatment with PFT-a decreased ETOP or MMS induced
BC expression (Fig. S8). These results indicated that p53 might
play a role in BC induction following GTXs treatment.
There are many genotoxicity mechanisms and the model
compounds selected in this work could not be expected to cover
all of them. More model compounds with diverse genotoxicity
mechanisms should be tested to further examine the sensitivity and
specificity of BC expression. An interesting finding in this study was
that BC correlated with DNA damage but not chromosomal lesion,
indicating that BC might not be appropriate in aneugen
genotoxicity prediction. Given both the in vivo (Fig. 1 and Table 2)
and in vitro data (Fig. 3), BC has the intrinsic ability to become a
sensitive biomarker of DNA damage. Although BC induction was
not obvious in response to colchicine and paclitaxel treatment, this
wouldnotcompromisethesensitivityofBCasapotentialbiomarker
of DNA damage, since colchicine and paclitaxel mainly target
microtubulesratherthanDNA.Additionally,itshouldbenotedthat
compounds that require S9 activation were excluded from the in
vitro study, in order to avoid potential S9 effects on BC expression. It
would be of great interest to examine the effects of indirect
genotoxic chemicals on BC expression in future studies. Moreover,
we are currently developing a GLN LTR driven luciferase reporter
gene system in NIH/3T3 cells, to facilitate toxicity screening in
early drug development [36,37,38,39].
The GLN family was recently reported to be potentially active
in the mouse genome [21], thus uncovering its cellular functions
would be of great significance. To the best of our knowledge, this is
the first report showing the involvement of a GLN family member
in cell growth regulation, thus providing basic information towards
a deeper understanding of its biological roles. Several studies have
Figure 5. Expression of BC could not be induced by GTXs and did not correlate with DNA damage in L5178Y cells. (A) Quantitative
PCR data showing transcriptional expression of BC in L5178Y cells treated with indicated chemicals for 4 h. Data were mean 6 s.d. of three
independent experiments. (B and C) Comparison between expression level of BC and DNA damage in L5178Y cells exposed to MMS for 8 h. DNA
damage was measured by olive tail moment (tail length6percentage of DNA in tail) in an alkaline comet assay (representative figures are shown in
C). Data were mean 6 s.d. of three independent experiments. (D) Linear regression analysis between expression level of BC and DNA damage,
reflected by olive tail moment. Each dot represents the mean of data shown in (B). Values shown on top of bars are P values vs control.
doi:10.1371/journal.pone.0035010.g005
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on certain cell lines [40,41]. One suggested mechanism was the
interaction of glycoproteins encoded by retroviral env genes with
cellular cytokine receptors, such as interleukin-2 receptor or
erythropoietin receptor. One study also suggested a role for env of
mink cell focus-forming (MCF) ERV in regulating pluripotent
hemopoietic progenitor proliferation. Given previous reports that
GLN was potentially active and might have an extracellular life
cycle similar to XRVs, it would be of great interest to study
whether GLN regulates cell growth through similar mechanisms.
Such studies will not only assist in a deeper understanding of its
biological function, but also provide theoretical support for its
application in genotoxicity prediction.
In summary, this is the first study to investigate the relationship
between ERVs and genotoxicity. We showed that expression level
of BC005512, a member from GLN family of murine ERV, was
elevated by multiple GTXs both in vivo and in vitro, and correlated
with the extent of DNA damage. It is thus possible that BC might
be useful as a potential molecular biomarker for assessment of
DNA damaging effects. Additionally, we first demonstrated that
BC was involved in cell growth regulation. This contributes to a
deeper understanding of the biological functions of BC005512 and
GLN, and provides fundamental support for their application in
genotoxicity predictions.
Materials and Methods
Ethics Statement
Animal-use protocols were approved by the Institutional Animal
Care and Use Committee of the Shanghai Institute of Materia
Medica (Shanghai, China) with IACUC No. 2010-10-RJ-05.
Animal treatment in microarray study
Two-month-old male B6C3F1 mice were given a single
intraperitoneal injection of model compounds or solvent control
(corn oil or saline) as listed in Table 1. O-AAT, DBP, DMBA and
Figure 6. Down-regulating BC expression suppressed cell growth in several mouse cell lines. (A, C and E) Quantitative PCR results
showing knock-down efficiency of BC siRNAs in NIH/3T3, Hepa 1–6 or SV40 MES 13 cells at 48 h after siRNA transfection. Data were mean 6 s.d. of at
least three independent experiments. (B, D and F) Cell numbers of NIH/3T3, Hepa 1–6 and SV40 MES 13 cells at indicated times after siRNA
transfection. Data were mean 6 s.d. of at least three independent experiments performed in triplicate. Values shown on top of bars are P values vs
nonsense.
doi:10.1371/journal.pone.0035010.g006
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dissolved in saline. Mice were sacrificed at 4 h, 20 h, 14 days or 28
days after administration and liver samples were collected
immediately. Animal administration was the same in the
quantitative PCR confirmation experiment except that B6C3F1
mice were substituted with C57BL/6 mice (supplied by Shanghai
Slac Laboratory Animal, Shanghai, China). DEHP and EtOH
were purchased from Sinopharm Chemical Reagent (Shanghai,
China), and other chemicals were from Sigma (St Louis, MO,
USA).
Microarray and data analysis
Five mg pooled total RNA of liver from 4 animals per group was
used as starting material. For each time point of each compound,
only one sample pooled from 4 animals was tested. cDNA
synthesis, cRNA labeling, and cRNA fragmentation were
conducted according to the manufacturer’s instructions (Affyme-
trix Inc., Santa Clara, CA, USA). The hybridization mixture was
hybridized to an Affymetrix Mouse Genome 430 2.0 array.
Hybridized arrays were washed and stained, and fluorescence
signals were detected using the Affymetrix GeneChip Scanner
3000. The image files were converted into expression data by the
Microarray Suite Software (Affymetrix) and the data was imported
into GeneSpring software (Silicon Genetics, Redwood City, CA,
USA). Signal intensity was normalized by per-gene and per-chip.
Ratio was calculated by normalizing treatment samples to solvent
control samples. The procedure was in compliance to MIAME
guidelines. The raw data has been deposited in GEO database
(GSE33248).
We used a step-wise selection criterion (set different significance
levels according to the intensity) in selecting differentially
expressed genes. For each time point of each chemical, genes
that met with either criterion listed in Table S1 were considered as
up-regulated genes and the corresponding cells in the Table S3
were marked with pink. While genes that met with either criterion
listed in Table S2 were considered as down-regulated genes and
the corresponding cells in the Table S3 were marked with blue.
Those selected up-regulated genes were further analyzed by self-
defined weight scoring based on several important parameters in
identifying genotoxic stress responsive genes (including specificity,
sensitivity, statistical P value, basal expression level, and coefficient
of variation) Detailed scoring rules are described in supporting
information (Text S1). Top 50 genes were further analyzed by
hierarchical clustering (average linkage clustering) by using Gene
Cluster and TreeView programs [42].
Cell lines and culture
NIH/3T3, Hepa 1–6 and SV40 MES 13 cells were purchased
from Type Culture Collection of Chinese Academy of Sciences
(http://www.cellbank.org.cn/index.asp). L5178Y cells were kindly
provided by Dr. M. Honma (NIHS, Japan) [43]. NIH/3T3 cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM,
Gibco BRL, Grand Island, NY, USA) supplemented with 10% calf
serum (Sijiqing Biological Engineering Materials, Hangzhou,
China). L5178Y cells were cultured in RPMI 1640 medium with
10% horse serum. Hepa 1–6 and SV40 MES 13 cells were
cultured in DMEM with 10% fetal bovine serum (FBS, Gibco) for
maintenance or in DMEM with 2.5% FBS for cell growth assay.
All cells were maintained at 37uCi n5 %C O 2.
Chemicals treatment in in vitro BC expression assay
Compounds that require metabolic activation were excluded to
avoid potential effects of S9 fraction on BC expression. The seven
selected genotoxins represent different mechanisms of action.
NIH/3T3 or L5178Y cells were treated with indicated concen-
tration of model compounds or irradiated with c-ray by
Figure 7. Knock-down of BC induced G1/S phase arrest and thus inhibited cell proliferation in NIH/3T3 cells. (A) Representative
fluorescent images of EdU incorporation assay. Blue nuclei represent total cells visualized by UV excitation, while red nuclei represent EdU-positive
cells visualized by green light excitation. (B) Quantitative analysis of EdU-positive cells (shown in A). A total of .4000 cells were counted for each
group. Data were mean 6 s.d. of three independent experiments. (C) Flow cytometric analysis of cell cycle in NIH/3T3 cells transfected with nonsense
or BC siRNAs at 48 h after siRNA transfection. 2n=cells in G0/G1 phase, and 4n=cells in G2/M phase. (D) Quantitative analysis of cell cycle phase
distribution (shown in C). Data were mean 6 s.d. of at least three independent experiments performed in triplicate. Values shown on top of bars are P
values vs nonsense.
doi:10.1371/journal.pone.0035010.g007
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listed in Table 3. After 4, 8, 12 and 24 h treatment or irradiation
for NIH/3T3, 4 h for L5178Y, cells were harvested and subjected
to RNA isolation and qPCR. MMC was purchase from Kyowa
(Tokyo, Japan), ACN from Merck (Darmstadt, Germany), SUC
from Sinopharm, and other chemicals were from Sigma.
Quantitative real-time PCR (qPCR)
Total RNA of mouse liver, NIH/3T3, L5178Y, Hepa 1–6 or
SV40 MES 13 cells was extracted by using the UNIQ-10 total
RNA isolation kit (Sangon Biotech, Shanghai, China). The
remnant genomic DNA in total RNA was digested by RNase-
free DNase I (Fermentas, Burlington, Canada). DNase-digested
RNA was further reverse transcribed into cDNA by using the
PrimeScript RT reagent kit (TaKaRa, Otus, Shiga, Japan).
DNase-digested RNA without reverse transcription was used as
a negative control. qPCR was carried out by using the SYBR
Premix Ex Taq (TaKaRa) with BC primers (forward: 59-
ATCACCCTGCATCCAGTTTAG -39, reverse: 59-
TATTGCCGCTAGGTCTTCATT -39) or GAPDH primers
(forward: 59-GGCTACACTGAGGACCAGGTT-39, reverse: 59-
TGCTGTAGCCGTATTCATTGTC-39). The qPCR conditions
were as follows: 95uC, 10 s; (95uC, 5 s, 60uC, 34 s) 40 cycles, with
a melting-curve process. Amplification process was performed on
7500 fast real-time PCR system (Applied Biosystems, Foster City,
CA, USA) and data was analyzed by using 2
2DDCt with the
Sequence Detection Software.
Alkaline comet assay
The alkaline comet assay was performed as previous described
with slight modifications [28]. Briefly, NIH/3T3 cells were
exposed to MMS for 8 h or to paclitaxel (Sigma) or colchicine
(Sigma) for 24 h. Then cells were trypsinized, resuspended in PBS,
mixed with 0.5% low-melting agarose and applied to glass slides
pre-coated with 1% normal-melting agarose. Slides mounted with
cells were immersed in cold lysing solution (2.5 M NaCl, 100 mM
EDTA, 10 mM Tris, 1% Triton X-100, 10% DMSO, pH=10;
the last two compounds were added fresh) for 2.5 h. After lysis,
slides were immersed in alkaline buffer (300 mM NaOH, 1 mM
EDTA, pH=13) for 20 min to allow DNA unwinding and DNA
breakage at alkali-labile sites. Then electrophoresis was performed
at 300 mA for 20 min. After electrophoresis, slides were
neutralized in 0.4 M Tris-HCl, dipped in ethanol and air-dried.
Cells were stained with SYBR Green and observed by a
fluorescent microscope (Olympus BX 51). At lease 100 cells were
pictured for each group, and olive tail moment (tail length6per-
centage of DNA in tail) was determined by image analysis software
Komet 5.5 (Kinetic Imaging, Liverpool, UK).
Micronucleus test
The micronucleus test was performed as described previously
with some modifications [44] [31]. Briefly, NIH/3T3 cells were
exposed to paclitaxel or colchicine for 24 h. Then the attached
cells were trypsinized, incubated in 0.075 M KCl hypotonic
solution, fixed in methanol-acetic acid (3:1) and finally suspended
in methanol containing 1% acetic acid. A drop of cell suspension
was placed on a clean glass slide and air-dried. Cells were stained
by mounting with acridine orange and immediately observed by a
fluorescent microscope (Olympus BX 51). The micronucleus
frequency was determined in 1000 total cells according to
published criteria [44], and cells with irregular shape of nucleus
were also counted as micronucleated cells. Cytochalasin B was not
used since it has been reported that the alteration of two
cytoskeletal elements, microtubules and microfilaments, concom-
itantly could influence the formation of micronucleated cells [45].
Cell transfection
Transfection of siRNA into NIH/3T3, Hepa 1–6 or SV40 MES
cells was conducted by using RNAiMAX (Invitrogen) with
50 pmol siRNA per 35 mm dish. BC siRNA-1 (siBC.1) targeting
59-CAGGUACCUCUAACUAUUAdTdT-39, BC siRNA-2
(siBC.2) targeting 59-CCAGUUUAGAAGAAAGCUAdTdT-39,
nonsense siRNA targeting 59- GCGACGAUCUGCCUAA-
GAUdTdT-39, scrambled-siBC.1 targeting 5-GAUCGAUAACC-
CAUCUUUAdTdT-3 and scrambled-siBC.2 targeting 5-
GCUAAUACUAGGCAAUGAAdTdT-3 were synthesized by
GenePharma (Shanghai, China). All siRNAs were chemically
modified with 29-fluoro-dU and 29-fluoro dC.
Cell growth assay
At 24, 48, 72 or 96 h after siRNA transfection, NIH/3T3, Hepa
1–6 or SV40 MES cells were trypsinized and cell numbers were
determined by using a Z1 Coulter counter (Beckman Coulter,
Fullerton, CA, USA).
EdU incorporation assay
EdU incorporation assay was performed by using Cell-Light
EdU DNA imaging kit (RiboBio, Guangzhou, China) according to
the manufacture’s instructions. Briefly, at 48 h after siRNA
transfection, NIH/3T3 cells were cultured in medium containing
50 mM EdU for 3.5 h. After EdU incorporation, cells were fixed in
4% paraformaldehyde and permeabilized by 0.5% Triton X-100.
After a click reaction between Apollo dye and ethynyl group in
EdU, EdU positive cells were visualized with a green light
excitation (550 nm), while total cells were visualized by Hoechst
33342 staining with UV excitation. At least a total of 4000 cells
were pictured for each group. EdU positive and total cells were
counted by using software Image-Pro Plus (Media Cybernetics,
Bethesda, MD, USA).
Cell cycle analysis
At 48 h after siRNA transfection, NIH/3T3 cells were
trypsinized, fixed in 70% ethanol, incubated with RNaseA, stained
with propidium iodide (Sigma) and analyzed by a FACSCalibur
(BD, Franklin Lakes, NJ, USA) instrument. Analysis of cell cycle
phase distribution was performed by using the Modfit software
(Verity Software House, Topsham, ME, USA).
Statistical analysis
Data were analyzed by Student’s unpaired t-test in Excel.
Differences were considered significant at *P,0.05, **P,0.01. For
BC expression study, the raw data was divided by that of control,
generating the normalized BC expression (folds of control). For
linear regression analysis, each dot in Fig. 4C represents the mean
of data shown in Fig. 4A, 4D and 4G. The linear regression
analysis was performed by using GraphPad Prism 5 (GraphPad
Software, Inc., La Jolla, CA, USA).
Supporting Information
Text S1 Supporting materials and methods.
(DOC)
Figure S1 Probe sequence (1426936_at) in Affymetrix
Mouse Genome 430 2.0 array.
(TIF)
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Hepa 1–6 cells. Quantitative PCR data showing transcriptional
expression of BC in Hepa 1–6 cells treated with CPT (3 mM),
MMC (100 mM), ETOP (50 mM) or MMS (0.5 mM) for indicated
times. Dose was 24 h IC50. Data were mean 6 s.d. of three
independent experiments.
(TIF)
Figure S3 Effects on BC expression in L5178Y cells
following MMS treatment at various time points. L5178Y
cells were treated with indicated concentrations of MMS. At
various time points after MMS incubation, cells were harvested
and expression levels of BC were analyzed by quantitative PCR.
Data were mean 6 s.d. of three independent experiments.
(TIF)
Figure S4 Specific effects of BC siRNAs on cell growth
and cell cycle progression. Expression level of BC (A), cell
number (B) and cell cycle phase distribution (C) in NIH/3T3 cells
transfected with indicated siRNAs at 48 h after transfection. Data
were mean 6 s.d. of at least three independent experiments
performed in triplicate. Values shown on top of bars are the P
values vs corresponding scrambled siRNA.
(TIF)
Figure S5 Representative western blot results showing
protein level knock-down efficiency and specificity of
siBC.2. NIH/3T3 cells were co-transfected with wild-type or
mutant myc tagged BC clone with nonsense siRNA or siBC.2. Cell
lysates were collected at 24 h after co-transfection. b-Actin served
as a loading control. Primary antibody against Myc tag was from
Cell Signaling (Danvers, MA, USA).
(TIF)
Figure S6 Flow cytometric analysis of apoptosis in
NIH/3T3 cells. NIH/3T3 cells were transfected with indicated
siRNAs. At 48 or 96 h after transfection, apoptosis was
determined using Annexin V-FITC Apoptosis Detection Kit (BD
Pharmingen) and a FACSCalibur (BD Pharmingen) instrument.
The lower right quadrant cells indicate early apoptotic cells, while
the upper right quadrant cells indicate late-apoptotic or dead cells.
(TIF)
Figure S7 The promoter/enhancer activity of wild-type
and p53 binding site deleted LTRs of GLN. (A) LTR
sequence of GLN. The sequence of the putative p53 binding site is
shown in bold and is consistent with the consensus p53 sequence
(59-RRRCWWGYYY-39, R=purine, Y=pyrimidine, W=A or
T). This putative p53 binding site was composed of two half-site
RRRCWWGYYY with no spacers. Right arrows indicate
RRRCW and left arrows indicate WGYYY. (B) Luciferase assay
of the GLN LTRs in NIH/3T3 cells. ‘‘Basic’’ and ‘‘Control’’
represents negative and positive control respectively. LTR-D
represents LTR with the putative p53 binding site deletion. LTR-
WT represents wild-type LTR. Data were mean 6 s.d. of at least
three independent experiments.
(TIF)
Figure S8 Effects of pifithrin-alpha (PFT-a) treatment
on GTX-induced BC expression in NIH/3T3 cells. NIH/
3T3 cells were treated with ETOP or MMS in combination with
indicated concentrations of PFT-a. Cells were harvested after 24 h
and BC expression was analyzed by quantitative PCR. Data were
mean 6 s.d. of three independent experiments. *P,0.05,
**P,0.01 vs PFT-a 0 mM.
(TIF)
Table S1 Step-wise criterion in selecting up-regulated
genes.
(DOC)
Table S2 Step-wise criterion in selecting down-regulated
genes.
(DOC)
Table S3 Raw data and detailed scoring rule of up-
regulated genes.
(XLS)
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